Home > Insider Trading > Filing (0001131096-17-000044)

Filing Details

Accession Number:: 0001131096-17-000044
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-03 21:47:44
Reporting Period:: 2017-03-01

Filing Date:: 2017-03-03
Accepted Time:: 2017-03-03 21:47:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131096	Athenahealth Inc	ATHN	Services-Business Services, Nec (7389)	043387530

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1653709	P Daniel Haley	C/O Athenahealth, Inc. 311 Arsenal Street Watertown MA 02472	Svp, Gc And Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-09-30	13	$107.20	13,173	No	5	J	Direct
Common Stock	Disposition	2017-03-01	105	$117.22	13,068	No	4	F	Direct
Common Stock	Disposition	2017-03-01	120	$117.22	12,948	No	4	F	Direct
Common Stock	Disposition	2017-03-01	305	$117.22	12,643	No	4	F	Direct
Common Stock	Disposition	2017-03-01	85	$117.22	12,558	No	4	F	Direct
Common Stock	Acquisiton	2017-03-01	1,549	$0.00	14,107	No	4	M	Direct
Common Stock	Disposition	2017-03-01	503	$117.22	13,604	No	4	F	Direct
Common Stock	Acquisiton	2017-03-01	2,559	$0.00	16,163	No	4	A	Direct
Common Stock	Disposition	2017-03-01	844	$117.40	15,319	No	4	S	Direct
Common Stock	Disposition	2017-03-01	896	$118.04	14,423	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	5	J	Direct
No	4	F	Direct
No	4	F	Direct
No	4	F	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Stock Unit	Disposition	2017-03-01	1,549	$0.00	1,549	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,879		2019-03-01	No	4	M	Direct

Footnotes

Shares purchased pursuant to the Issuer's 2007 Employee Stock Purchase Plan on September 30, 2016, which transaction is considered exempt pursuant to Rule 16b-3(c) promulgated under the Securities Exchange Act of 1934.
Includes 13,090 Restricted Stock Units (each, an "RSU") that are subject to time-based vesting and will be settled only in stock. Of the 13,090 unvested RSUs, 9,375 were previously reported by the Reporting Person as derivative securities, and 3,715 were subject to awards granted to the Reporting Person prior to his designation as a Section 16 officer. Effective March 1, 2017, the Reporting Person has determined to report RSU awards that are subject to time-based vesting and only settled in stock as non-derivative securities in his ownership reports.
Each Performance Stock Unit ("PSU") converts into common stock on a one-for-one basis.
The securities acquired are units of common stock that were granted pursuant to a RSU award under the athenahealth, Inc. 2007 Stock Option and Incentive Plan, as amended and restated. The RSUs are subject to time-based vesting and will be settled only in stock.
The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of November 1, 2016, in accordance with Rule 10b5-1.
Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.21 to $117.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote (6).
Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.57 to $118.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote (7).
13,760 of these securities are units of common stock granted pursuant to RSU awards. The units are subject to time-based vesting.
Each PSU represents a contingent right to receive one share of the Issuer's common stock.
On March 1, 2016, the Reporting Person was granted a performance stock unit ("PSU") award of 5,817 PSUs. The PSUs vest in three equal annual installments beginning on March 1, 2017 based on the Issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2016. On February 7, 2017, the Compensation Committee of the Board of Directors of the Issuer certified that the performance criteria for 2016 was met, resulting in vesting of PSUs as to 1,549 shares on March 1, 2017.